Antimicrobial resistance in the chronically critically ill patient

Clin Chest Med. 2001 Mar;22(1):87-103, viii. doi: 10.1016/s0272-5231(05)70027-7.

Abstract

Infection caused by organisms resistant to conventional antimicrobial therapy is an emerging problem of global proportions. This article describes the epidemiology of infections caused by resistant organisms in chronically critically ill patients and explores factors and mechanisms that lead to the development of resistance. Specific organisms and strategies for the treatment and control of these resistance organisms are discussed.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / adverse effects
  • Anti-Bacterial Agents / therapeutic use*
  • Bacterial Infections / drug therapy*
  • Bacterial Infections / microbiology
  • Candida / drug effects
  • Critical Care*
  • Cross Infection / drug therapy*
  • Cross Infection / microbiology
  • Drug Resistance, Multiple*
  • Gram-Negative Bacteria / drug effects
  • Gram-Positive Cocci / drug effects
  • Humans
  • Microbial Sensitivity Tests

Substances

  • Anti-Bacterial Agents